Unlock stock picks and a broker-level newsfeed that powers Wall Street.
IOB - Delayed Quote EUR

Dermapharm Holding SE (0A5J.IL)

Compare
36.40
+0.38
+(1.04%)
At close: April 4 at 5:45:04 PM GMT+1
Loading Chart for 0A5J.IL
  • Previous Close 36.03
  • Open 36.55
  • Bid 32.65 x --
  • Ask 39.35 x --
  • Day's Range 35.50 - 36.65
  • 52 Week Range 30.15 - 42.20
  • Volume 11,519
  • Avg. Volume 49,261
  • Market Cap (intraday) 2.006B
  • Beta (5Y Monthly) 1.13
  • PE Ratio (TTM) 15.96
  • EPS (TTM) 2.28
  • Earnings Date May 15, 2025
  • Forward Dividend & Yield 1.05 (2.75%)
  • Ex-Dividend Date Jun 15, 2023
  • 1y Target Est --

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription healthcare products, herbal extracts, and other pharmaceutical products. It offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. The company also provides medical devices under the bite away and Herpotherm names. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG.

ir.dermapharm.de

3,404

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0A5J.IL

View More

Performance Overview: 0A5J.IL

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

0A5J.IL
3.89%
DAX P (^GDAXI)
3.68%

1-Year Return

0A5J.IL
17.62%
DAX P (^GDAXI)
12.16%

3-Year Return

0A5J.IL
33.19%
DAX P (^GDAXI)
42.18%

5-Year Return

0A5J.IL
27.24%
DAX P (^GDAXI)
116.69%

Compare To: 0A5J.IL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0A5J.IL

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    1.95B

  • Enterprise Value

    2.81B

  • Trailing P/E

    17.25

  • Forward P/E

    15.17

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.66

  • Price/Book (mrq)

    3.24

  • Enterprise Value/Revenue

    2.38

  • Enterprise Value/EBITDA

    8.75

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.65%

  • Return on Assets (ttm)

    9.07%

  • Return on Equity (ttm)

    24.70%

  • Revenue (ttm)

    1.15B

  • Net Income Avi to Common (ttm)

    122.56M

  • Diluted EPS (ttm)

    2.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    110.78M

  • Total Debt/Equity (mrq)

    210.84%

  • Levered Free Cash Flow (ttm)

    187.7M

Research Analysis: 0A5J.IL

View More

Company Insights: 0A5J.IL

Research Reports: 0A5J.IL

View More

People Also Watch